• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为了更好地了解 CKD 中的动脉钙化疾病进展:对早期病理改变的研究。

Towards a better understanding of arterial calcification disease progression in CKD: investigation of early pathological alterations.

机构信息

Laboratory of Pathophysiology, University of Antwerp, Wilrijk, Belgium.

Laboratory of Physiopharmacology, University of Antwerp, Wilrijk, Belgium.

出版信息

Nephrol Dial Transplant. 2023 May 4;38(5):1127-1138. doi: 10.1093/ndt/gfac301.

DOI:10.1093/ndt/gfac301
PMID:36316014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10320369/
Abstract

BACKGROUND

Cardiovascular disease remains the leading cause of death in chronic kidney disease (CKD) patients, especially in those undergoing dialysis and kidney transplant surgery. CKD patients are at high risk of developing arterial media calcifications (AMC) and arterial stiffness. We hypothesized that investigation of disease progression at an early stage could provide novel insights in understanding AMC etiology.

METHODS

An adenine diet was administered to male Wistar rats to induce AMC. Rats were sacrificed after 2, 4 and 8 weeks. AMC was measured by assessment of aortic calcium and visualized using histology. Arterial stiffness was measured in vivo by ultrasound and ex vivo by applying cyclic stretch of physiological magnitude on isolated arterial segments, allowing us to generate the corresponding pressure-diameter loops. Further, ex vivo arterial reactivity was assessed in organ baths at 2 and 4 weeks to investigate early alterations in biomechanics/cellular functionality.

RESULTS

CKD rats showed a time-dependent increase in aortic calcium which was confirmed on histology. Accordingly, ex vivo arterial stiffness progressively worsened. Pressure-diameter loops showed a gradual loss of arterial compliance in CKD rats. Additionally, viscoelastic properties of isolated arterial segments were altered in CKD rats. Furthermore, after 2 and 4 weeks of adenine treatment, a progressive loss in basal, nitric oxide (NO) levels was observed, which was linked to an increased vessel tonus and translates into an increasing viscous modulus.

CONCLUSIONS

Our observations indicate that AMC-related vascular alterations develop early after CKD induction prior to media calcifications being present. Preventive action, related to restoration of NO bioavailability, might combat AMC development.

摘要

背景

心血管疾病仍然是慢性肾脏病(CKD)患者死亡的主要原因,尤其是在接受透析和肾移植手术的患者中。CKD 患者发生动脉中层钙化(AMC)和动脉僵硬的风险较高。我们假设在早期阶段研究疾病进展可以为理解 AMC 的病因提供新的见解。

方法

给予雄性 Wistar 大鼠腺嘌呤饮食以诱导 AMC。大鼠在 2、4 和 8 周后被处死。通过评估主动脉钙来测量 AMC,并通过组织学可视化。通过超声在体内测量动脉僵硬,通过对分离的动脉段施加生理幅度的循环拉伸在体外测量,使我们能够生成相应的压力-直径环。此外,在 2 和 4 周时在器官浴中评估离体动脉反应性,以研究生物力学/细胞功能的早期变化。

结果

CKD 大鼠的主动脉钙呈时间依赖性增加,组织学证实了这一点。相应地,体外动脉僵硬逐渐恶化。压力-直径环显示 CKD 大鼠的动脉顺应性逐渐丧失。此外,在 CKD 大鼠中,分离的动脉段的粘弹性特性发生改变。此外,在腺嘌呤治疗 2 和 4 周后,观察到基础一氧化氮(NO)水平逐渐降低,这与血管张力增加有关,并转化为粘性模量增加。

结论

我们的观察结果表明,在 AMC 相关血管改变发生在中层钙化之前,在 CKD 诱导后早期就已经发生。与恢复 NO 生物利用度相关的预防措施可能会对抗 AMC 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/c5034aabf981/gfac301fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/3750c58a4451/gfac301fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/f8fecaf2bf37/gfac301fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/02489dea6472/gfac301fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/9d924403d650/gfac301fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/a9a637fa2786/gfac301fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/c4a5f8d0cfdd/gfac301fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/c5034aabf981/gfac301fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/3750c58a4451/gfac301fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/f8fecaf2bf37/gfac301fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/02489dea6472/gfac301fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/9d924403d650/gfac301fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/a9a637fa2786/gfac301fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/c4a5f8d0cfdd/gfac301fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf4/10320369/c5034aabf981/gfac301fig6.jpg

相似文献

1
Towards a better understanding of arterial calcification disease progression in CKD: investigation of early pathological alterations.为了更好地了解 CKD 中的动脉钙化疾病进展:对早期病理改变的研究。
Nephrol Dial Transplant. 2023 May 4;38(5):1127-1138. doi: 10.1093/ndt/gfac301.
2
Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease.血管重构和中膜钙化增加慢性肾脏病患者的动脉僵硬度。
Clin Exp Hypertens. 2014;36(3):173-80. doi: 10.3109/10641963.2013.804541. Epub 2013 Jun 20.
3
Endothelial dysfunction aggravates arterial media calcification in warfarin administered rats.华法林给药大鼠内皮功能障碍加重动脉中层钙化。
FASEB J. 2022 May;36(5):e22315. doi: 10.1096/fj.202101919R.
4
Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.二甲双胍可预防严重慢性肾脏病及其相关矿物质和骨代谢紊乱的发生。
Kidney Int. 2018 Jul;94(1):102-113. doi: 10.1016/j.kint.2018.01.027. Epub 2018 Apr 30.
5
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.在一种改良的、基于腺嘌呤的尿毒症大鼠模型中,磷酸盐结合剂可预防磷酸盐诱导的血管平滑肌细胞衰老和血管钙化。
Calcif Tissue Int. 2015 Apr;96(4):347-58. doi: 10.1007/s00223-014-9929-5. Epub 2014 Dec 16.
6
Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.内皮素A型受体阻断可减轻慢性肾脏病大鼠的血管钙化和炎症。
J Hypertens. 2017 Feb;35(2):376-384. doi: 10.1097/HJH.0000000000001161.
7
Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.交联壳聚糖铁(III)对尿毒症大鼠血管钙化的影响。
Exp Biol Med (Maywood). 2018 May;243(9):796-802. doi: 10.1177/1535370218775035.
8
Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.在晚期慢性肾脏病中,动脉僵硬度的进展与骨矿物质标志物的变化有关。
BMC Nephrol. 2017 Sep 4;18(1):281. doi: 10.1186/s12882-017-0705-4.
9
Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.镁与抑制血管钙化的临床生物标志物的关系。
Am J Nephrol. 2012;35(1):31-9. doi: 10.1159/000334742. Epub 2011 Dec 15.
10
Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification.炎症细胞因子和活性氧作为慢性肾脏病相关血管钙化的介质
Am J Hypertens. 2015 Jun;28(6):746-55. doi: 10.1093/ajh/hpu225. Epub 2014 Nov 27.

引用本文的文献

1
Mineral Stress Drives Loss of Heterochromatin: An Early Harbinger of Vascular Inflammaging and Calcification.矿物质应激导致异染色质丢失:血管炎性衰老和钙化的早期预兆。
Circ Res. 2025 Feb 14;136(4):379-399. doi: 10.1161/CIRCRESAHA.124.325374. Epub 2025 Jan 22.
2
Monitoring of microvascular calcification by time-resolved photoacoustic microscopy.通过时间分辨光声显微镜监测微血管钙化
Photoacoustics. 2024 Nov 7;41:100664. doi: 10.1016/j.pacs.2024.100664. eCollection 2025 Feb.
3
Triiodothyronine and Protein Malnutrition Could Influence Pulse Wave Velocity in Pre-Dialysis Chronic Kidney Disease Patients.

本文引用的文献

1
Endothelial dysfunction aggravates arterial media calcification in warfarin administered rats.华法林给药大鼠内皮功能障碍加重动脉中层钙化。
FASEB J. 2022 May;36(5):e22315. doi: 10.1096/fj.202101919R.
2
Endothelial Contribution to Warfarin-Induced Arterial Media Calcification in Mice.内皮细胞在华法林诱导的小鼠动脉中层钙化中的作用
Int J Mol Sci. 2021 Oct 27;22(21):11615. doi: 10.3390/ijms222111615.
3
Chronic Kidney Disease-Induced Arterial Media Calcification in Rats Prevented by Tissue Non-Specific Alkaline Phosphatase Substrate Supplementation Rather Than Inhibition of the Enzyme.
三碘甲状腺原氨酸和蛋白质营养不良可能影响透析前慢性肾脏病患者的脉搏波速度。
Diagnostics (Basel). 2023 Jul 24;13(14):2462. doi: 10.3390/diagnostics13142462.
补充组织非特异性碱性磷酸酶底物而非抑制该酶可预防大鼠慢性肾病诱导的动脉中层钙化。
Pharmaceutics. 2021 Jul 26;13(8):1138. doi: 10.3390/pharmaceutics13081138.
4
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病:病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
5
Lack of Endothelial Nitric Oxide Synthase Accelerates Ectopic Calcification in Uremic Mice Fed an Adenine and High Phosphorus Diet.缺乏内皮型一氧化氮合酶加速了高磷饮食加腺嘌呤喂养的尿毒症小鼠的异位钙化。
Am J Pathol. 2021 Feb;191(2):283-293. doi: 10.1016/j.ajpath.2020.10.012. Epub 2020 Nov 4.
6
Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.蔗糖铁氧羟化物在慢性肾衰竭大鼠模型中的肾保护作用。
Nephrol Dial Transplant. 2020 Oct 1;35(10):1689-1699. doi: 10.1093/ndt/gfaa080.
7
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update.慢性肾脏病中的内皮功能障碍:从生物学机制到临床结局——2020年更新
J Clin Med. 2020 Jul 23;9(8):2359. doi: 10.3390/jcm9082359.
8
Uremic Toxins and Vascular Dysfunction.尿毒症毒素与血管功能障碍
Toxins (Basel). 2020 Jun 18;12(6):404. doi: 10.3390/toxins12060404.
9
Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.乙二醇低聚物衍生的肌醇磷酸盐抑制血管钙化。
Nat Commun. 2020 Feb 5;11(1):721. doi: 10.1038/s41467-019-14091-4.
10
The Vicious Cycle of Arterial Stiffness and Arterial Media Calcification.动脉僵硬度与动脉中膜钙化的恶性循环。
Trends Mol Med. 2019 Dec;25(12):1133-1146. doi: 10.1016/j.molmed.2019.08.006. Epub 2019 Sep 12.